XDNY:F:F-Xtrackers MSCI Japan ESG Screened UCITS ETF 1D (EUR)

ETF | Others |

Last Closing

USD 15.622

Change

-0.09 (-0.59)%

Market Cap

USD 60.46B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-11 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-1.25 (-4.78%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-2.60 (-5.20%)

USD 109.57B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-2.75 (-5.10%)

USD 94.40B
SXR8:F iShares Core S&P 500 UCITS ETF..

-15.44 (-2.90%)

USD 89.51B
SXRZ:F iShares VII PLC - iShares Nikk..

-11.85 (-5.18%)

USD 55.46B
VUSA:F Vanguard Funds Public Limited ..

-2.92 (-3.06%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

-3.15 (-3.30%)

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 38.74B
0ZC:F Zscaler Inc

-10.06 (-6.09%)

USD 37.92B
BSND:F Danone SA

-0.10 (-0.86%)

USD 33.83B

ETFs Containing XDNY:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.10% 74% C 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.10% 72% C 63% D
Trailing 12 Months  
Capital Gain 14.94% 64% D 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.94% 61% D- 60% D-
Trailing 5 Years  
Capital Gain 31.10% 54% F 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 31.10% 54% F 48% F
Average Annual (5 Year Horizon)  
Capital Gain 4.43% 58% F 60% D-
Dividend Return 4.43% 56% F 53% F
Total Return N/A 68% D+ 95% A
Risk Return Profile  
Volatility (Standard Deviation) 11.67% 57% F 82% B
Risk Adjusted Return 37.95% 56% F 63% D
Market Capitalization 60.46B 99% N/A 97% N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike